Observational Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Aug 28, 2021; 27(32): 5448-5459
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5448
Table 1 Patients clinical characteristics upon admission
Patients
Age
Sex
Comorbidities
Ongoing ACT/APT
Entry symptoms
D-dimer
185MHT, CVDYesLow GI bleedingNot done
271FHTYesLoss of appetite, vomiting, low GI bleeding10 N
369MDM, liver cirrhosisNoDiarrhoea, fever and dyspnea8 N
479FHT, CVD, HCVYesAbdominal pain8 N
563MNoNoLower limb pain> 70 N
662MObesity, DM, HT, liver cirrhosisNoAbdominal pain and vomiting> 70 N
783FHTYesAbdominal pain and dyspnoea4 N
865MNoNoAbdominal painNot done
988MCVDYesAbdominal painN
1079MCVDNo Cardiac failureN
1156MHCV, liver cirrhosisNo Ascites5 N
1261MDM, HTNoDyspnoea3 N
1378FHTYes Lower limb oedema8 N
1441MNo No Fever and mental slowdown6 N
1564FHTYesFever and caught2 N
1689FAlzheimer diseaseYesCaught and diarrhoea N
1759MObesity, HTNoShortness of breathing2 N
1874MCVD, pharynx carcinomaNoLoss of conscious4 N
1963MDM, HTNoFever, caught and dyspnoea2 N
2062FHCV, COPDNoMelena and anaemiaNot done
2172MParkinson disease and dementiaNoFever and dysuria> 70 N

  • Citation: Norsa L, Bonaffini PA, Caldato M, Bonifacio C, Sonzogni A, Indriolo A, Valle C, Furfaro F, Bonanomi A, Franco PN, Gori M, Smania V, Scaramella L, Forzenigo L, Vecchi M, Solbiati M, Costantino G, Danese S, D'Antiga L, Sironi S, Elli L. Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study. World J Gastroenterol 2021; 27(32): 5448-5459
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i32/5448.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i32.5448